Gary S. Hogge, SVP, Clinical & Medical Affairs at Lineage Cell Therapeutics, Inc. (LCTX), sold 1,069,316 shares at $2.45 ($2.6M) on 2021-12-28, disclosed to the SEC on 2021-12-30.
Open-market sale of $2.6M LCTX by SVP, Clinical & Medical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.45 | 501,588 | $1.2M | 46.9% |
| 2 | $2.45 | 501,588 | $1.2M | 46.9% |
| 3 | $2.44 | 28,445 | $69K | 2.6% |
| 4 | $2.44 | 28,445 | $69K | 2.6% |
| 5 | $2.49 | 9,250 | $23K | 0.9% |
| Total | $2.45 avg | 1,069,316 |
| $2.6M |
| 100% |